Long-chain saturated fatty acid species are not toxic to human pancreatic β-cells and may offer protection against pro-inflammatory cytokine induced β-cell death

Weight problems is a significant danger issue for sort 2 diabetes (T2D) though the causal hyperlinks stay unclear. A function shared by each circumstances nonetheless is systemic irritation and raised ranges of circulating fatty acids (FFA). It’s broadly believed that in overweight people genetically liable to T2D, elevated ranges of plasma FFA might contribute in the direction of the dying and dysfunction of insulin-producing pancreatic β-cells in a means of (gluco)lipotoxicity.

In assist of this, in vitro research have proven persistently that long-chain saturated fatty acids (LC-SFA) are poisonous to rodent β-cells throughout persistent publicity (> 24 h). Conversely, shorter chain SFA and unsaturated species are nicely tolerated, suggesting that toxicity depends on carbon chain size and/or double bond configuration. Regardless of the wealth of proof implicating lipotoxicity as a method of β-cell dying in rodents, the proof {that a} comparable course of happens in people is far much less substantial. Subsequently, the current examine has evaluated the results of persistent publicity to fatty acids of various chain size and diploma of saturation, on the viability of human β-cells in tradition.

We now have additionally studied the results of a mix of fatty acids and pro-inflammatory cytokines. Strikingly, we discover that LC-FFA don’t readily promote the demise of human β-cells and that they might even supply a measure of safety towards the poisonous results of pro-inflammatory cytokines. Subsequently, these findings indicate {that a} mannequin wherein elevated circulating LC-FFA play a direct function in mediating β-cell dysfunction and dying in people, could also be overly simplistic.

Enriching for human acute myeloid leukemia stem cells utilizing reactive oxygen species-based cell sorting

Isolation of leukemia stem cells presents a problem as a result of heterogeneity of the immunophenotypic markers generally used to establish blood stem cells. A number of research have reported that relative ranges of reactive oxygen species (ROS) can be utilized to complement for stem cell populations, suggesting a possible different to floor antigen-based strategies.

Right here, we describe a protocol to complement for stem cells from human acute myeloid leukemia specimens utilizing relative ranges of ROS. This protocol offers constant enrichment of leukemia stem cells. For full particulars on the use and execution of this protocol, please confer with Lagadinou et al. (2013) and Pei et al. (2018).

Substrate Stiffness, Cell Anisotropy, and Cell–Cell Contact Contribute to Enhanced Structural and Calcium Dealing with Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) will be utilized to know the mechanisms underlying the event and development of coronary heart illness, in addition to to develop higher interventions and coverings for this illness. Nonetheless, these cells are structurally and functionally immature, which undermines a few of their adequacy in modeling grownup coronary heart tissue.

Earlier research with immature cardiomyocytes have proven that altering substrate stiffness, cell anisotropy, and/or cell-cell contact can improve the contractile and structural maturation of hPSC-CMs. On this examine, the structural and calcium dealing with properties of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) have been enhanced by publicity to a downselected mixture of those three maturation stimuli. First, hESC-CMs have been seeded onto substrates composed of two business formulations of polydimethylsiloxane (PDMS), Sylgard 184 and Sylgard 527, whose stiffness ranged from 5 kPa to 101 kPa. Upon analyzing the morphological and calcium transient properties of those cells, it was concluded {that a} 21 kPa substrate yielded cells with the best diploma of maturation.

Subsequent, these PDMS substrates have been microcontact-printed with laminin to pressure the classy cells into rod-shaped geometries utilizing line patterns that have been 12, 18, or 24 μm in width. We discovered that cells on the 18 and 24 μm sample widths had structural and useful properties that have been superior to these on the 12 μm sample.

The hESC-CMs have been then seeded onto these line-stamped surfaces at a density of 500 000 cells per 25-mm-diameter substrate, to allow the formation of cell-cell contacts at their distal ends. We found that this mixture of tradition circumstances resulted in cells that have been extra structurally and functionally mature than those who have been solely uncovered to at least one or two stimuli. Our outcomes recommend that downselecting a mix of mechanobiological stimuli may show to be an efficient technique of maturing hPSC-CMs in vitro.

Laser-Primarily based Hybrid Manufacturing of Endosseous Implants: Optimized Titanium Surfaces for Enhancing Osteogenic Differentiation of Human Mesenchymal Stem Cells

Additive manufacturing (AM) is turning into more and more vital within the orthopedic and dental sectors thanks to 2 main benefits: the potential of customized manufacturing and the combination of advanced buildings. Nonetheless, at smaller scales, floor circumstances of AM merchandise are usually not mastered. Quite a few non-fused powder particles give rise to roughness values (Sa) higher than 10 μm, thus limiting biomedical purposes for the reason that floor roughness of, e.g., metallic implants performs a significant function within the high quality and charge of osseointegration.

On this examine, an progressive hybrid machine combining AM and a femtosecond laser (FS) was used to acquire Ti6Al4V elements with biofunctional surfaces. In the course of the manufacturing course of, the FS laser beam “neatly” ablates the floor, leaving in its path nanostructures created by the laser/matter interplay. This step decreases the Sa from 11 to four μm and will increase the floor wettability.

The conduct of human mesenchymal stem cells was evaluated on these new AM+FS surfaces and in contrast with that on AM surfaces and likewise on polished surfaces. The variety of cells hooked up 24 h after plating is equal on all surfaces, however cell spreading is greater on AM+FS surfaces in contrast with their AM counterparts. In the long term (days 7 and 14), fibronectin and collagen synthesis improve on AM+FS surfaces versus AM alone.

Alkaline phosphatase exercise, osteocalcin manufacturing, and mineralization, markers of osteogenic differentiation, are considerably decrease on uncooked AM surfaces, whereas on the AM+FS specimens they show a degree equal to that on the polished floor. Total, these outcomes point out that utilizing an FS laser beam through the fabrication of AM elements optimizes floor morphology to favor osteoblastic differentiation.

CD1B Antibody
1-CSB-PA004890ESR2HU	Cusabio	EUR 266.40 EUR 402.00	100ul 50ul
Description: A polyclonal antibody against CD1B. Recognizes CD1B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

CD1B Antibody
DF10150	Affbiotech	200ul	EUR 420

CD1b Antibody
F46544-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens. [provided by RefSeq].

CD1b Antibody
F46544-0.4ML	NSJ Bioreagents	0.4 ml	EUR 322.15
Description: This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens. [provided by RefSeq].

CD1b Antibody
RQ4547	NSJ Bioreagents	100ug	EUR 356.15
Description: CD1b is a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens.

CD1b Antibody
V2028-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody
V2028-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody
V2028SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody
V2950-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

CD1b Antibody
V2950-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

CD1b Antibody
V2950SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

T-Cell Surface Glycoprotein CD1b (CD1B) Protein
20-abx263315	Abbexa	EUR 1930.80 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
20-abx320708	Abbexa	EUR 526.80 EUR 393.60	100 ul 50 ul

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
20-abx006357	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
abx139084-01mg	Abbexa	0.1 mg	EUR 427.2

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
abx030324-400ul	Abbexa	400 ul	EUR 627.6

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
abx030324-80l	Abbexa	80 µl	EUR 343.2

T-cell Surface Glycoprotein CD1b (CD1B) Antibody
20-abx009480	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

T-cell Surface Glycoprotein CD1b (CD1B) Antibody (PE)
abx140369-100tests	Abbexa	100 tests	EUR 577.2

CD1B Rabbit pAb
A6551-100ul	Abclonal	100 ul	EUR 369.6

CD1B Rabbit pAb
A6551-200ul	Abclonal	200 ul	EUR 550.8

CD1B Rabbit pAb
A6551-20ul	Abclonal	20 ul	EUR 219.6

CD1B Rabbit pAb
A6551-50ul	Abclonal	50 ul	EUR 267.6

CD1b(100-1A5) Antibody
BNC401044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC401044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC551044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC551044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC431044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC431044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC471044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF647 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC471044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF647 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC801044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC801044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC811044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC811044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC611044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC611044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNUM1044-50	Biotium	50uL	EUR 474
Description: Primary antibody against CD1b(100-1A5), 1mg/mL

CD1b(100-1A5) Antibody
BNCB1044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCB1044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCP1044-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(100-1A5), PerCP conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC941044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC941044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCAP1044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCAP1044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCA1044-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(100-1A5), APC conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCH1044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCH1044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNUB1044-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against CD1b(100-1A5), Concentration: 0.2mg/mL

CD1b(100-1A5) Antibody
BNUB1044-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against CD1b(100-1A5), Concentration: 0.2mg/mL

CD1b(100-1A5) Antibody
BNC041044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC041044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC051044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC051044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC701044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC701044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC881044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC881044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC681044-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNC681044-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody
BNCR1044-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(100-1A5), RPE conjugate, Concentration: 0.1mg/mL

CD1b Antibody (FITC)
abx139085-100tests	Abbexa	100 tests	EUR 510

Human T- cell surface glycoprotein CD1b, CD1B ELISA KIT
ELI-50259h	Lifescience Market	96 Tests	EUR 988.8

CD1b(RIV12) Antibody
BNC470317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF647 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC470317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF647 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC550317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC550317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC400317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC400317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC430317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC430317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC810317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC810317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC610317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC610317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNUM0317-50	Biotium	50uL	EUR 474
Description: Primary antibody against CD1b(RIV12), 1mg/mL

CD1b(RIV12) Antibody
BNCB0317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCB0317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCP0317-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(RIV12), PerCP conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCA0317-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(RIV12), APC conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCAP0317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCAP0317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC940317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC940317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCH0317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCH0317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNUB0317-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against CD1b(RIV12), Concentration: 0.2mg/mL

CD1b(RIV12) Antibody
BNUB0317-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against CD1b(RIV12), Concentration: 0.2mg/mL

CD1b(RIV12) Antibody
BNC040317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC040317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC050317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC050317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC700317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC700317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC880317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC880317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC800317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC800317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC680317-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNC680317-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody
BNCR0317-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against CD1b(RIV12), RPE conjugate, Concentration: 0.1mg/mL

Human T-cell surface glycoprotein CD1b(CD1B) ELISA kit
CSB-EL004890HU-24T	Cusabio	1 plate of 24 wells	EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human T-cell surface glycoprotein CD1b (CD1B) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human T-cell surface glycoprotein CD1b(CD1B) ELISA kit
1-CSB-EL004890HU	Cusabio	EUR 964.80 EUR 6118.80 EUR 3244.80	1 plate of 96 wells 10 plates of 96 wells each 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human T-cell surface glycoprotein CD1b(CD1B) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Rabbit T- cell surface glycoprotein CD1b, CD1B ELISA KIT
ELI-10666Ra	Lifescience Market	96 Tests	EUR 1113.6

CD1B cloning plasmid
CSB-CL004890HU-10ug	Cusabio	10ug	EUR 279.6
Description: A cloning plasmid for the CD1B gene.

CD1b Blocking Peptide
20-abx062369	Abbexa	EUR 326.40 EUR 493.20	1 mg 5 mg

CD1B Blocking Peptide
DF10150-BP	Affbiotech	1mg	EUR 234

CD1B Polyclonal Antibody
46805-100ul	SAB	100ul	EUR 302.4

CD1B Polyclonal Antibody
46805-50ul	SAB	50ul	EUR 224.4

CD1B Polyclonal Antibody
ABP58043-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of CD1B from Human. This CD1B antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD1B protein at amino acid sequence of 60-100

CD1B Polyclonal Antibody
ABP58043-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of CD1B from Human. This CD1B antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD1B protein at amino acid sequence of 60-100

CD1B Polyclonal Antibody
ABP58043-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of CD1B from Human. This CD1B antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD1B protein at amino acid sequence of 60-100

CD1B Conjugated Antibody
C46433	SAB	100ul	EUR 476.4

CD1B Polyclonal Antibody
ES8672-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against CD1B from Human. This antibody is tested and validated for IHC, WB, ELISA

CD1B Polyclonal Antibody
ES8672-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against CD1B from Human. This antibody is tested and validated for IHC, WB, ELISA

Anti-Hu CD1b PE
1P-761-T025	ExBio	25 tests	EUR 168

This new hybrid machine may make it attainable to provide AM implants with useful surfaces straight on the finish of AM, thereby limiting their post-treatments.